Xiaofei Wang | Duke Department of Biostatistics and Bioinformatics
“ Temporal Trends in the Utilization and Survival Outcomes of Lobar, Segmental, and Wedge Resection for Early-Stage NSCLC, 2004 to 2020. ” JTO Clinical and Research Reports 6, no. …
Xiaofei Wang | Scholars@Duke profile
Member of the Duke Cancer Institute · 2015 - Present Duke Cancer Institute, Institutes and Centers Recent Publications Temporal Trends in the Utilization and Survival Outcomes of …
Xiaofei Wang | Professor of Biostatistics & Bioinformatics | Duke ...
2019-2026 Brigham and Women's Hospital. 2019-2026 Mayo Clinic - Rochester. 2021-2025 Alliance Foundation Trials, LLC.
B&B Faculty Receives R01 Grant With Positions Open For Postdoc …
May 8, 2020 · Dr. Xiaofei Wang has received a four-year NIH/NIA R01 grant as the multi-PI on developing methods combining clinical trials and real-world evidences studies for better …
Xiaofei Wang - Duke University School of Medicine
2424 Erwin Road Suite 1102, 11080 Hock Plaza, Duke Box 272, Durham, NC 27705
Faculty Xiaofei Wang, PhD, Named A 2021 Fellow Of The …
Aug 11, 2021 · Faculty Xiaofei Wang, PhD, was recently named a 2021 Fellow of the American Statistical Association (ASA). He joins eleven other members of the B&B Department as an …
Xiaofei Wang | Sandbox - Duke University
Xiaofei Wang; Contact Info. [email protected]. 2424 Erwin Road Suite 1102, 11080 Hock Plaza, Duke Box 272, Durham, NC 27705. Professor of Biostatistics & Bioinformatics. Member …
Xiaofei Wang - Professor of Biostatistics & Bioinformatics - Duke ...
Biostatistician at Duke University Medical Center · Experience: Duke University Medical Center · Location: Durham · 500+ connections on LinkedIn. View Xiaofei Wang’s profile on LinkedIn, a...
- Title: Biostatistician at Duke …
- Location: Duke University Medical Center
- 500+ connections
Xiaofei Wang | Scholars@Duke profile: Research
2020 Duke - Industry Statistical Symposium (DISS) Inst. Training Prgm or CME Principal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2020 - 2021
Xiaofei Wang | Scholars@Duke profile: Publications
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis. Journal Article J Immunother Cancer · February 4, 2025 …
- Some results have been removed